Available online on 15.07.2024 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2024 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Research Article
Antimicrobial Activity and Phytochemical analysis of Evolvulus alsinoides against HIV Secondary Pathogens
ISHIMWE Alain Prudence 1,2 *, MIGABO Hiberte 2, Tuyishime Jean de Dieu 2, NZEYIMANA Godefroid 2
1 Department of Microbiology, Muthayammal College of Arts and Science, Rasipuram- 637408, Tamilnadu, India.
2 Department of Biomedical Laboratory Sciences, INES-Ruhengeri, Institute of Applied Fundamental Sciences, Musanze, RWANDA.
|
Article Info: ___________________________________________ Article History: Received 14 Feb 2024 Reviewed 07 April 2024 Accepted 27 May 2024 Published 15 July 2024 ___________________________________________ Cite this article as: Alain Prudence I, Hiberte M, Jean de Dieu T, Godefroid N, Antimicrobial Activity and Phytochemical analysis of Evolvulus alsinoides against HIV Secondary Pathogens, Journal of Drug Delivery and Therapeutics. 2024; 14(7):97-101 DOI: http://dx.doi.org/10.22270/jddt.v14i7.6452 ___________________________________________ *Address for Correspondence: ISHIMWE Alain Prudence, Ines-Ruhengeri, Faculty of Applied Fundamental Sciences, Department of Biomedical Laboratory Sciences, Rwanda. |
Abstract ___________________________________________________________________________________________________________________ Background: The antimicrobial activities of medicinal plants have long been exploited by scientific community against the diseases causing microorganisms. Routine use of antibiotic agents developed microbes as drug resistant organisms making it as a critical issue in case of treatments. So the detection of new natural compounds with antimicrobial activity is considered to be important. Although hundreds of plant species have been said to have antimicrobial properties, the vast majority have not been adequately evaluated. The present research works focus to develop new therapeutic agents or drug from selected medicinal plant of Evolvulus alsinoides against HIV Secondary pathogenic organisms, based on the review of literature, problems associated with treatment of pathogenic organisms and drug resistant patterns of the pathogenic organisms. Results: The isolated bacterial cultures from secondary infection of HIV patient’s samples were identified as Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa based on their Morphology, Staining, Motility and Biochemical test. The isolated fungal cultures were identified as, Aspergillus niger, Penicillium sp, Mucor sp, and Candida albicans, based on their growth and LCB staining. Evolvulus alsinoides has shown to have several compounds that play a great function in its antimicrobial activity. Conclusion: There is a need to develop alternative agents for the control of pathogenic bacterial and fungal diseases in HIV infected persons. There is a good reason to support that the secondary metabolites of plants have evolved to protect them from attack by microbial pathogens. Hence, products from plants have great potential as sources of novel bioactive compounds for controlling pathogenic microorganisms. The treatment of various infectious diseases by the support of traditional usage of herbal medicine indicates the therapeutic potential of Evolvulus alsinoides by its antimicrobial activity. Further clinical studies are required to validate the efficacy of this medicinal plant against various pathogens and various resistant strains of bacteria. Keywords: Evolvulus alsinoides, HIV Secondary Pathogens, Solvent extracts, antimicrobial activity, Phytochemical Analysis. |
INTRODUCTION
Human Immunodeficiency Virus (HIV) causes acquired immunodeficiency syndrome (AIDS) and a flurry of life-threatening opportunistic infections. Though this virus was discovered more than a decade ago there are no treatment methodologies available to date to completely cure this disease.HIV binds to CD4 receptors on helper T-lymphocytes and then the CD4 cells migrate to the lymphoid tissues. In the lymphoid tissues the virus gets replicated and then infects new CD4-positive cells. As the infection continues, depletion or impaired function of CD4 cells predisposes to the development of immune dysfunction. Globally Sexual transmission is the most common mode of transmission of HIV. Obviously, the probability of a person being infected via sexual intercourse depends on the likelihood of unprotected sex with an infected partner, so sexual behavior patterns are of major importance1. In individuals with healthy immune systems, the symptoms of AIDS are primarily the result of conditions that mostly cause opportunistic infections that are normally controlled by the elements of the immune system which HIV damages.2
Antiretroviral drugs are now available to inhibit the replication of HIV. These drugs involved in restoring the patient's immune system to something approaching normal activity and reduce the chances of opportunistic infection developing to prolong life. Current antiretroviral drugs are vitally important to improve the quality and prolong the life of HIV/AIDS patients. However, these drugs have many disadvantages including resistance, toxicity, limited availability, high cost and lack of any curative effect. Thus, it is important to search for improved antiretroviral agents which can be added to or replace the current drugs in the anti-HIV arma mentarium. Some plants are identified as an excellent source of anti-HIV agents. South Africa has a rich plant biodiversity and a long tradition of medicinal use of plants with approximately 3000 species of plants used as medicines.3 Preferred initial therapy is usually three drugs: efavirenz plus tenofovir or abacavir, plus lamivudine or emtricitabine. Other drugs are used in particular circumstances.4
Before 1990s, the problem of antimicrobial resistance was never taken to be such a threat to the management of infectious diseases. But gradually treatment failures were increasingly being seen in health care settings against first-line drugs and second-line drugs or more. Recently the drug resistant nature of the microorganisms was increasingly to ensure their survival against the arsenal of antimicrobial agents to which they were being bombarded.5
There is a need to develop alternative agents for the control of pathogenic bacterial and fungal diseases in HIV infected persons. There is a good reason to support that the secondary metabolites of plants have evolved to protect them from attack by microbial pathogens. Hence, products from plants have great potential as sources of novel bioactive compounds for controlling pathogenic microorganisms. In general, plant-derived natural substances are considered as non-toxic and potentially effective against many pathogens. In recent years, interests have been generated in the development of safer antimicrobial agents such as plant-based essential oils and extracts to control many diseases.6
Nature has been a supply of therapeutic agents for thousands of years and a powerful range of contemporary medicine are derived from natural sources. Numerous active compounds derived from medicinal plants are assessed for the effectivity and tolerability within the treatment of various diseases. Medicinal plants are identified and used to treating against various disease in human history. Plants consist several chemical compounds that are involved in various biological functions, together with defense against Micro organisms like Bacteria, Virus, Fungi, Protozoa and saprozoic mammals. The chemical compounds in plants mediate their impact on the organic structure through processes the image of those already well understood for the chemical compounds in standard medicine; therefore, Herbal medicines don't disagree greatly from standard drugs in terms of however they work. Treatment with medicinal plants is taken into account terribly safe as there's no or lowest side effect. The Medicinal plants are an expensive resource of ingredients which might be employed in drug development either pharmacopoeial, non pharmacopoeial or artificial medicine.
Evolvulus alsinoides is a flowering plants belongs to the Convolvulaceae family. It is a natural equatorial distribution encompassing tropical and warm-temperate regions of India, Australia, Polynesia, Africa and also Americas. Evolvulus alsinoides could be a terribly slender, a lot of or less branched, spreading or ascending, typically extraordinarily bushy herb. The stems are 20-70 cm long and not twining. The leaves that are densely clothed with close, white and glossy hairs, are variable clothed, unsubdivided to ovate and frequently 0.5-1.0 cm in length; the apex is blunt with a touch purpose and also the base is pointed. The flowers are pale blue and 6-8 millimeter in diameter. Evolvulus alsinoides has been found to contain Shankhapushpine.7 Evolvine (alkaloid, structure currently unknown). Evolvoids A and B which appear to be caffeic acid bound to two 2-methyl-1, 2, 3, 4-butanetetrol molecules and two caffeic acid molecules found to glucose (respectively).8 .Evolvosides C, D, and E which are triglycosides of kaempferol. Evolvoside C (4′-O-β-d-glucopyranosyl-α-l-rhamnopyranosyl-β-d-glucopyranoside),D(O-methyl derivative of C), and E (di-O-methyl derivative of C).9 Other Kaempferol glycosides such as 4′-O-β-d-glucopyranosyl-β-d-glucopyranoside,4′-O-α-l-rhamnopyranosyl-β-d-glucopyranoside,7-di-O-β-d-glucopyranoside,3-O-β-d-glucopyranosyl-β-d-glucopyranoside,and3-O-β-d-glucopyranosyl-7-O-α-l-rhamnopyranoside.9,10 These bio-active compounds consist of both Antibacterial and Antifungal activity reported by the previous workers.
Vitexin and 4-methoxyvitexin.7 Quercetin as 3-O-β-glucopyranoside.8,11 Betaine (second hand reports).12 Scopoletin13 and scopolin (coumarin and coumarin glucoside).12 Umbelliferone (coumarin) 2-methyl-1,2,3,4-butanetetrol,1,3-di-O-caffeoyl quinic acid methyl ester and caffeic acid β-sitosterol, these compounds are identified by the GCMS and checked by their Antimicrobial activity against HIV Secondary pathogens.12
The present research works focus to; do develop new therapeutic agents or drug from selected medicinal plant of Evolvulus alsinoides against HIV Secondary pathogenic organisms, based on the review of literature, problems associated with treatment of pathogenic organisms and drug resistant patterns of the pathogenic organisms.
MATERIALS AND METHODS:
Sample Collection and processing:
The samples from secondary infection of HIV patients were collected from clinical laboratory at Government Hospital, Rasipuram. The specimens were transported immediately to the microbiology laboratory and processed without any delay. The samples were inoculated into the Nutrient Broth and incubated at 37˚C for 24 hours, and also the samples were inoculated into Sabouraud Dextrose Broth and incubated at 25˚C for 3 days.
After incubation the bacterial samples were inoculated on the Nutrient Agar medium and incubated at 37˚ C for 24 hours and also the fungal samples were inoculated into Sabouraud Dextrose Agar medium incubated at 25˚C for 3 days. The organisms were subjected for further studies.
PREPARATION OF PLANT EXTRACT
Identification of plant materials
The plant authenticated by Botanical Survey of India (BSI-Southern Circle) - Government of India, Coimbatore, Tamil Nadu. Fresh leaves of Evolvulus alisnoides were collected from Kolli Hills, Tamilnadu and washed several times with water to remove the dust particles. The leaves of Evolvulus alisnoides were air dried at room temperature. Size reduction of plant material was done with the help of grinder to form powder.
Solvent selection
The following solvent Methanol, Ethanol, Petroleum ether and Chloroform was selected for extraction.
Extraction of Evolvulus alisnoides (leaves)
10 grams of Evolvulus alsinoides powder was used for extraction process. The extraction process was carried out by Maceration procedure. The 10gm Evolvulus alsinoides of with 100ml of all 4 solvents in beaker and kept in shaker at 70rpm for 3-4 days at room temperature.
PHYTOCHEMICAL ANALYSIS OF PLANT EXTRACTS:
Qualitative chemical tests were carried out using extract from plant to identify the phytochemicals. Preliminary phytochemical screening was carried out to find the presence of the active chemical constituents in extracts such as alkaloids, flavonoids, tannins, carbohydrates, phenolic compounds, terpenoids, glycosides, steroids, fixed oils and fats. In general, tests for the presence of phytochemical compounds involved the addition of appropriate chemical reagent(s) to the extract in test tubes.
The alkaloid was tested by using Mayer’s test, the flavonoids were tested by lead acetate test. The tannins were tested by ferric chloride test. The total phenolic content in extract was determined by ferric chloride test. Steroids tested by salkowski test. The terpenoids tested by chloroform and con.sulphuric acid. The Carbohydrate was tested by benedict’s test. The glycoside was tested by Aqueous NaOH.14
Antibacterial activity of Evolvulus alisnoides against isolated organisms
The antibacterial activity was carried out by well diffusion method. The sterile Muller Hinton agar plate was prepared. The isolated test organisms, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa were spread over the Muller Hinton agar plates by using separate sterile cotton swabs.
The well was prepared with plant extract in 100µl concentration on Muller- Hinton agar plates with the following extracts, Petroleum ether, Chloroform, Ethanol, and Methanol. The plates were incubated for 24 hours at 37˚C. The zone of inhibition of bacterial growth was measured.
Antifungal activity of Evolvulus alisnoides against isolated organisms
The antifungal activity was carried out by Well diffusion method. The sterile Muller Hinton agar plate was prepared. The isolated test organisms, Aspergillus niger, Penicillium sp, Mucor sp and Candida albicans, were spread over the Muller Hinton agar plates by using separate sterile cotton swabs.
The well was prepared with plant extract in 100µl concentration on Muller- Hinton agar plates with the following extracts, Petroleum ether, Chloroform, Ethanol, and Methanol. The plates were incubated for 2-4 days at 37˚C. The zone of inhibition of fungal growth was measured.
RESULT AND DISCUSSION
Identification of isolated organisms
The isolated bacterial cultures from secondary infection of HIV patient’s samples were identified as Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa based on their Morphology, Staining, Motility and Biochemical test.
The isolated fungal cultures were identified as, Aspergillus niger, Penicillium sp, Mucor sp, and Candida albicans, based on their growth and LCB staining.
Identification of plant materials
The plant authenticated by Botanical Survey of India (BSI-Southern Circle) Government of India, Coimbatore, Tamil Nadu. A voucher specimen no is BSI/SRC/5/23/2016/Tech: 278, and the voucher was deposited at Department of Microbiology, MCAS, Rasipuram.
Phytochemical analysis of Evolvulus alisnoides
Phytochemical analysis of Evolvulus alisnoides was carried out by the following solvents Methanol, Ethanol, Petroleum ether and Chloroform.
In Methanol extract of Evolvulus alisnoides contain the components, Alkaloids, flavonoids, tannin, terpenoids, glycosides, phenolic compounds and steroids are present. Whereas the Ethanol extract of Evolvulus alisnoides contain the constituents, Alkaloids, flavonoids, tannin, terpenoids, glycosides, phenolic compounds and steroids are present. In Chloroform extract of Evolvulus alisnoides contain Tannin and phenolic compounds. Petroleum ether extract of Evolvulus alisnoides contains flavonoids, and Sugars are present. The predominant components present in all the extracts of Evolvulus alisnoides are Tannins, Phenols and Flavonoids (Table: 1)
The preliminary phytochemical screening carried out showed Evolvulus alsinoides contain some secondary metabolites such as glycosides, alkaloids, saponins, volatile oil, flavonoids and tannins. In general, secondary metabolites present in plants have been reported by Rabe.15 to be responsible for therapeutic activity. Singh & Bhat 16 reported that flavonoids are responsible for the antimicrobial activity associated with some ethnomedicinal plants.
|
Constituents |
Ethanol |
Methanol |
Petroleum ether |
Chloroform |
|
Alkaloids |
+ |
+ |
- |
- |
|
Flavonoids |
+ |
+ |
+ |
- |
|
Tannin |
+ |
+ |
- |
+ |
|
Carbohydrate |
- |
- |
+ |
- |
|
Terpenoids |
+ |
+ |
- |
- |
|
Glycosides |
+ |
+ |
- |
- |
|
Steroids |
+ |
+ |
- |
- |
|
Phenols |
+ |
+ |
- |
+ |
+: Present – : Absent
Antibacterial activity of Evolvulus alisnoides
The antibacterial effects of Plant extract of Evolvulus alisnoides had been investigated against isolated Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The well was prepared with plant extract in 100µl concentration and the wells were placed on Muller-Hinton agar plates (Table: 2)
|
Organisms |
Concentration of extract and zone of inhibition (mm) |
|
|||
|
Methanol extract (100µl) |
Ethanol extract (100µl) |
Chloroform extract (100µl) |
Petroleum ether extract (100µl) |
||
|
Staphylococcus aureus |
03 |
03 |
01 |
05 |
|
|
Klebsiella pneumoniae |
4.5 |
3.5 |
0.5 |
03 |
|
|
E.coli |
08 |
3.5 |
5.5 |
5.5 |
|
|
Pseudomonas aeruginosa |
- |
- |
- |
- |
|
The results clearly showed that Methanol, chloroform and Petroleum ether extracts were specific in action against the growth of bacteria. From this results, Methanol extract highly inhibit the growth of E.coli and Klebsiella. Whereas in Petroleum ether extract strongly inhibit the growth of E.coli and S.aureus
The similar investigation carried out by Kannan Elangovan et al., (2013) the antibacterial activity of the crude extracts of E. alsinoides was tested against gram-positive Staphylococcus aureus and gram-negative Salmonella typhi, Acinetobacter baumannii, Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa using agar well diffusion method. Among all the extracts, aqueous showed higher activity followed by ethanol, ethyl acetate, chloroform and hexane.17
Antifungal activity of Evolvulus alisnoides
The antifungal effects of Plant extract of Evolvulus alisnoides had been investigated against isolated Aspergillus niger, Penicillium sp, Mucor sp, and Candida albicans. (Table: 3)
The well was prepared with plant extract in 100µl concentration and the well was placed on Muller-Hinton agar plates.
|
Organisms |
Concentration of extract and zone of inhibition (mm) |
|||
|
Methanol Extract (100µl) |
Ethanol extract (100µl) |
Chloroform Extract (100µl) |
Petroleum ether Extract (100µl) |
|
|
Aspergillus niger |
02 |
1.5 |
1 |
1.5 |
|
Penicillium sps |
1.5 |
01 |
- |
02 |
|
Mucor sps |
03 |
5.5 |
2.5 |
3.5 |
|
Candida albicans |
04 |
01 |
- |
02 |
The results clearly showed that ethanol, methanol, Chloroform and Petroleum ether extracts were specific in action against the growth of fungal culture. From the result, Methanol extract inhibit the growth of all fungal strains like Aspergillus niger, Penicillium sps , Mucor sps and Candida albicans.
Additionally, the ethanolic extract of the whole plant of Evolvulus alsinoides also showed the bactericidal activity against various clinical pathogens including Staphylococcus aureus, Vibrio cholera, Salmonella thypi.18 However, in another study, it was found that the ethanolic extract of Evolvulus alsinoides (whole plant) exhibited the antibacterial activity against Pseudomonas aeruginosa and Escherichia coli but found effective against Staphyloccus aureus, Aspergillus niger and Candida albicans.19
The presence of glycosides and alkaloids in Evolvulus alsinoides may be associated with their use by traditional medicine practitioners in healthcare systems in the treatment of fever, antibacterial and antifungal and venereal diseases. The results of this research highlight the fact that the methanol extracts exhibited greater antimicrobial activity because the antimicrobial principles. This inspection agrees with the report of other investigators of medicinal plants that organic solvents are more suitable for extraction of phytochemicals. The similar research work reported other researchers.20,21
E. alsinoides (L.) L, exhibited antimicrobial properties against Acinetobacter baumannii, Aspergillus niger, Cryptococcus neoformans and Candida albicans and mild activity against Bacillus subtilis, Klebsiella pneumonia, Pseudomonas aeruginosa and Staphylococcus aureus when acetone extract was used, whereas methanolic extract is found to be highly effective.22,23
CONCLUSION
There is a need to develop alternative agents for the control of pathogenic bacterial and fungal diseases in HIV infected persons. There is a good reason to support that the secondary metabolites of plants have evolved to protect them from attack by microbial pathogens. Hence, products from plants have great potential as sources of novel bioactive compounds for controlling pathogenic microorganisms. In general, plant-derived natural substances are considered as non-toxic and potentially effective against many pathogens. In recent years, interests have been generated in the development of safer antimicrobial agents such as plant-based essential oils and extracts to control many diseases. The treatment of various infectious diseases by the support of traditional usage of herbal medicine indicates the therapeutic potential of Evolvulus alsinoides by its antimicrobial activity. Further clinical studies are required to validate the efficacy of this medicinal plant against various pathogens and various resistant strains of bacteria.
DECLARATIONS
Ethics approval and consent to participate
The permission to conduct this study was approved by the department of Microbiology, Muthayammal College of Arts and Sciences and the plant authenticated by Botanical Survey of India (BSI-Southern Circle) - Government of India, Coimbatore, Tamil Nadu. A voucher specimen no is BSI/SRC/5/23/2016/Tech: 278, and the voucher was deposited at Department of Microbiology, MCAS, Rasipuram.
Consent for publication: NA
Availability of data and materials: All data generated or analysed during this study are included in this published article
Competing interests: NA
Funding: This work has not funded by any institution or organization.
Authors' contributions: Ishimwe Alain Prudence designed the study and do the experiments to achieve the results, other author participated in the manuscript writing and reading.
Acknowledgements: NA
Consent for Publication: NA
REFERENCES
1. Robinson N.J., Silarug N., Surasiengsunk S., Auvert B., Hanenberg R., Two million HIV infections prevented in Thailand: estimate of the impact of increased condom use. XI International AIDS Conference, Vancouver,1996; [Abstract Mo. C904].
2. Holmes C.B., Losina E., Walensky R.P., Yazdanpanah Y., Freedberg K.A., Review of Human Immunodeficiency Virus type 1-related opportunistic infections in sub-Saharan Africa. Clin. Infect. Dis.2003; 36 (5): 656-662. https://doi.org/10.1086/367655 PMid:12594648
3. Van Wyk, B., Gericke, N. (Eds.) People's Plants: A Guide to Useful Plants of South Africa, first ed. Briza Publications, South Africa. 2000;10-12.
4. Kaplan J.E., Benson C., Holmes K.H., Guidelines for prevention and treatment of opportunistic infections in MMWR Recomm Rep. 2009;58(4):1-207.
5. Leclerq R. and Courvalin P. Resistance to glycopeptides in enterococci. Clin. Infect. Dis.1997; 24: 545-556. https://doi.org/10.1093/clind/24.4.545 PMid:9145724
6. Bhuyan D.J. and Barooah M.S. Evaluation of antifungal, antibacterial and Antioxidant activities of Amphineuron extensus, Hedyotis diffusa and Vitex negundo. Journal of Cell and Tissue Research. 2012;12 (3) 3343-3348.
7. Sethiya NK, Ashish Trivedi, Mayur B. Patel, and S. H. Mishra. Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India . J Adv Pharm Technol Res. 2010;1(4): 388-395. https://doi.org/10.4103/0110-5558.76437 PMid:22247878 PMCid:PMC3255406
8. Gupta P, Akanksha, Siripurapu KB, Ahmad A, Palit G, Arora A, Maurya R. Anti-stress constituents of Evolvulus alsinoides: an ayurvedic crude drug . Chem Pharm Bull (Tokyo).2007;55(5):771-5. https://doi.org/10.1248/cpb.55.771 PMid:17473466
9. Gupta P, Sharma U, Gupta P, Siripurapu KB, Maurya R. Bioorg Med Chem. Evolvosides C-E, flavonol-4-O-triglycosides from Evolvulus alsinoides and their anti-stress activity. Bioorg Med Chem.2013; 1;21(5):1116-22. https://doi.org/10.1016/j.bmc.2012.12.040 PMid:23357036
10. Manmeet Kumar, Ausaf Ahmad, Preeti Rawat, Rakesh Maurya Kumar M, Antioxidant flavonoid glycosides from Evolvulus alsinoide. Fitoterapia. Fitoterapia.2010; 81(4):234-42 https://doi.org/10.1016/j.fitote.2009.09.003 PMid:19748554
11. Cervenka F, Jahodár L .Plant metabolites as nootropics and cognitives. Ceska Slov Farm.2006; 7454(2): 19-23.
12. Cervenka F, Koleckar V, Rehakova Z, Jahodar L, Kunes J, Opletal L, Hyspler R, Jun D, Kuca K. Evaluation of natural substances from Evolvulus alsinoides L. with the purpose of determining their antioxidant potency . J Enzyme Inhib Med Chem.2008;23(4):574-8. https://doi.org/10.1080/14756360701674421 PMid:18666003
13. Nahata A, and Dixit VK. Spectrofluorimetric Estimation of Scopoletin in Evolvulus alsinoides Linn. and Convulvulus pluricaulis Choisy . Indian J Pharm Sci. 2008;37(7): 23-28.
14. Evans W.C. and Trease G.E. A text book of Pharmacognosy. Bailliare Tindall and Cassel. 2008;14th ed., 2008, 13.
15. Rabe, T. S. J.Isolation of an Antimicrobial sesquiterpenoid from Warbugie salutaris. Journal of Ethnopharmacology.2000; 93:171- 174. https://doi.org/10.1016/S0378-8741(00)00293-2 PMid:11025153
16. Singh, I. & Singh, V., P. Antifungal properties of aqueous and organic solution extracts of seed plants against Aspergillus flavus and A. niger. Phytomorphol. 2000; 50: 151-157.
17. Kannan Elangovan, Kumar Supriya, Kandhasamy Murugesan and Rajamani Aravind Screening of Phytochemicals and In vitro Antioxidant activity of Evolvulus alsinoides L.. Journal of Academia and Industrial Research.2013; 2(4). 230-234.
18. Dhanalekshmi UM, Poovi G, Kishore N, Raja MD, Reddy PN. Evaluation of wound healing potential and antimicrobial activity of ethanolic extract of Evolvulus alsinoides. Annals of Biological Research 2010;1: 49-61.
19. Dash GK, Suresh P, Sahu SK, Kar DM, Ganapaty S, Evaluation of Evolvulus alsinoides Linn for anthelmintic and antimicrobial activities. Journal of Natural Remedies 2002;2: 182-185.
20. Natarajan, D., Britto J. S., Srinivasan, K., Nagamurugan, N., Mohanasundari, C. & Perumal, G. Antibacterial activity of Euphorbia fusiformis - a rare medicinal herb Journal of Ethnopharmacology.2005; 102: 123-126. https://doi.org/10.1016/j.jep.2005.04.023 PMid:16159702
21. Singh, I. & Singh, V., P. Antifungal properties of aqueous and organic solution extracts of seed plants against Aspergillus flavus and A. niger. Phytomorphol.2000; 50:151-157.
22. Vijayan MN, Ida B, Seema D, Shital D and Astrida R.. Antimicrobial activity of ten common herbs, commonly known as 'Dashapushpam' from Kerala, India. African Journal of Microbiology Research .2017;4(22):2357-2362
23. Gomathi RL and Elango V. In vitro antimicrobial activity and phytochemical analysis of few Indian medicinal plants. International Journal of Science and Research .2015;4(8):659-663